Half-Dose Flu Vaccine Study in Healthy Adults

NCT00006146 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

840

Enrollment

NIH

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Approved influenza virus vaccine.

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)